Waters Corporation $WAT Shares Acquired by J. Goldman & Co LP

Posted by Brian Himes on Aug 26th, 2026

J. Goldman & Co LP grew its stake in shares of Waters Corporation (NYSE:WAT – Free Report) by 24.0% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 16,483 shares of the medical instruments supplier’s stock after purchasing an additional 3,190 shares during the quarter. J. Goldman & Co LP’s holdings in Waters were worth $6,182,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. California Public Employees Retirement System increased its position in shares of Waters by 25.4% in the 1st quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock valued at $41,222,000 after acquiring an additional 28,074 shares during the period. Banque Cantonale Vaudoise grew its stake in Waters by 329.0% during the 4th quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock valued at $1,631,000 after purchasing an additional 3,293 shares during the last quarter. Ramsay Stattman Vela & Price Inc. purchased a new stake in Waters during the 1st quarter valued at about $942,000. Dudley & Shanley Inc. increased its holdings in shares of Waters by 101.3% in the second quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock valued at $8,847,000 after purchasing an additional 11,870 shares during the period. Finally, Hahn Capital Management LLC acquired a new stake in shares of Waters during the first quarter worth about $1,490,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Price Performance

NYSE:WAT opened at $414.41 on Wednesday. The company has a 50 day moving average price of $383.92 and a 200-day moving average price of $347.45. Waters Corporation has a 1-year low of $282.77 and a 1-year high of $421.74. The firm has a market cap of $40.72 billion, a price-to-earnings ratio of 103.34, a price-to-earnings-growth ratio of 2.39 and a beta of 1.19. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 1.29.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The firm’s revenue was up 113.3% on a year-over-year basis. During the same quarter last year, the business earned $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Equities research analysts forecast that Waters Corporation will post 14.56 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on WAT shares. JPMorgan Chase & Co. upped their target price on Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Sanford C. Bernstein initiated coverage on shares of Waters in a report on Friday, June 26th. They issued an “outperform” rating and a $435.00 price objective on the stock. Wolfe Research began coverage on shares of Waters in a report on Tuesday, June 2nd. They set an “outperform” rating and a $425.00 target price for the company. HSBC upped their price target on shares of Waters from $415.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, June 3rd. Finally, Weiss Ratings lowered Waters from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Waters presently has an average rating of “Moderate Buy” and an average price target of $420.35.

Check Out Our Latest Stock Report on WAT

Insider Buying and Selling at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of the company’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the transaction, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.31% of the stock is currently owned by corporate insiders.

Waters Company Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.